Abstract
Ever since the redefinition of myocardial infarction (MI) in the year 2000,1 a new entity has entered the field: non-ST-elevation MI (NSTEMI). STEMI and NSTEMI share the release of specific myocardial necrosis markers which define them clinically as acute MI (AMI) and set them apart from unstable angina, an acute coronary syndrome which does not qualify as MI. With the creation of the NSTEMI as a new clinical entity, the need for data regarding prognosis and treatment options arose. By definition, STEMI and NSTEMI are only different with respect to the reflection of acute myocardial ischaemia and necrosis in the ECG. Although this difference may be triggered by the size of the infarcted area, it may also be only the location of the infarct—an occluded … *Corresponding author. Tel: +49 761 270 3441; fax: +49 761 270 3200. E-mail address : christoph.bode{at}uniklinik-freiburg.de